Cipla (CIPLA) — Corporate Action

Cipla announced the allotment of 49,931 equity shares under its ESOS 2013-A and ESAR 2021 schemes on May 26, 2025, increasing the paid-up share capital to ₹1,615.38 crores from ₹1,566.45 crores, reflecting a 3.1% rise in total capital. This issuance dilutes existing shareholders' ownership proportionally as new shares were created from the employee option pool without cash inflow.

📄 View Original Announcement (PDF)

📊 Stock Analysis — CIPLA ✨ Ask AI About This

About Cipla Limited (CIPLA)

Healthcare · Pharmaceuticals & Biotechnology · Listed on NSE

Market Cap: ₹1,15,682.55 Cr P/E: 25.4 ROE: 14.6% ROCE: 19.4%

View full CIPLA stock details →

📡 Get AI alerts when CIPLA files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track CIPLA — Free

💡 Ask AI about this filing

"How does this corporate action affect Cipla Limited's outlook?" "What did Cipla Limited announce on 26 May 2025?" "Is this positive or negative for CIPLA?"

Ask AI Free →

📊 More CIPLA filings

See all CIPLA filings →

🔥 Also filed on 26 May 2025

DIVISLAB Divi's Laboratories Limited Corporate Action SBICARD SBI Cards and Payment Services Limited Corporate Action INDUSINDBK IndusInd Bank Limited Financial Results JSWSTEEL JSW Steel Limited Financial Results LT Larsen & Toubro Limited Annual Report ICICIBANK ICICI Bank Limited Board Meeting

View all today's announcements →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when CIPLA files new disclosures

Track CIPLA filings, board meetings, and corporate actions. Free email alerts at 5 PM.